HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $140
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and lowers the price target from $152 to $140.
Balchem’s Return on Invested Capital Overview
According to Benzinga Pro data Balchem (NASDAQ:BCPC) posted a 15.22% decrease in earnings from Q2. Sales, however, increased…
Balchem Q2 EPS $1.07 Beats $1.00 Estimate, Sales $236.69M Beat $225.49M Estimate
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $1.00 by 7 percent. This is a 15.05 percent increase over earnings of $0.93 per share from the same period
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 211 companies set new 52-week lows.
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $152
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and lowers the price target from $155 to $152.
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $155
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and lowers the price target from $170 to $155.
Sidoti & Co. Upgrades Balchem to Buy, Announces $175 Price Target
Sidoti & Co. analyst Mitra Ramgopal upgrades Balchem (NASDAQ:BCPC) from Neutral to Buy and announces $175 price target.
Balchem Q4 Adj. EPS $0.85, Inline, Sales $213.13M Beat $198.17M Estimate
Balchem (NASDAQ:BCPC) reported quarterly earnings of $0.85 per share which met the analyst consensus estimate. This is a 2.41 percent increase over earnings of $0.83 per share from the same period last year. The company
Earnings Scheduled For February 18, 2022
Companies Reporting Before The Bell
• DraftKings (NASDAQ:DKNG) is likely to report quarterly loss at $0.79 per share on revenue of $445.18 million.